GLUC — Glucose Health Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro Cap

Annual income statement for Glucose Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2014 December 31st	2015 December 31st	2016 December 31st	2020 December 31st	2021 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.003	0.004	0.313	0.481	0.954
Cost of Revenue
Gross Profit	0	0	0.019	0.174	0.41
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	0.563	0.171	0.4	1.12	1.29
Operating Profit	-0.56	-0.167	-0.087	-0.639	-0.336
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.669	-0.266	-0.41	-0.478	-0.339
Provision for Income Taxes
Net Income After Taxes	-0.669	-0.266	-0.41	-0.478	-0.339
Net Income Before Extraordinary Items
Net Income	-0.669	-0.266	-0.41	-0.478	-0.339
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.669	-0.266	-0.41	-0.527	-0.438
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.939	-0.131	-0.147	-0.045	-0.034
Dividends per Share